calcimedica inc glp-1 receptor agonists weight management diabetes treatments agonist 🔴GLP-1 receptor in patients with chronic kidney disease and either overweight or obesity⤵️ #2024Review #openaccess 🔹https://academic.oup.com/ckj/article/17 Indications for GLP-1/GIP RA Summary
Description
doi: 10.1248/bpb.b14-00505 10 MaoDCaoHShiMWangCCKwongJLiJJXet al
doi: 10.1111/dom.12963 [DOI] [PMC free article] [PubMed] [Google Scholar] 172.Gamble JM, Chibrikov E, Midodzi WK, et al
Key side effects include: Nausea: Many people get this when they first use it
The information and data provided is for information purposes only
Importantly, SMM declined slightly in absolute terms, yet its proportion relative to total BW was preserved
